Putting quality of life back within reach.

The unmet needs of essential tremor represent a significant market opportunity.

LARGE US AND GLOBAL MARKET POTENTIAL

UP TO 50%

DO NOT RESPOND TO RX THERAPY

Few effective prescription medications are available for treating ET. Between 30% to 50% of patients do not respond to either first line pharmacological agents: propanol and primidone²

ANNUAL INCREASE IN POPULATIONS WITH ET

Due to the aging population, the number of individuals with ET is expected to experience annual double digit growth¹

60%

MILITARY VETERANS³

Reference:

Global Essential Tremor Treatment Market Report 2018 by QYR Pharma & Healthcare Research Center
Zesiewicz TA, Kuo S-H. Essential tremor. BMJ Clin Evid. 2015;2015:1206. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681313. Accessed February 2, 2018.
Readi-steadi glove website